-
GEN – Genetic Engineering & Biotechnology News3 months ago
The Three Pillars of Successful AI Deployments
Artificial intelligence and machine learning (AI/ML) are breakthrough tools in biopharmaceutical processing, but they are only as good as the dynamic processes they interact with. You...
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Biopharma Benefitting from AI in Manufacturing
Biopharma is embracing artificial intelligence (AI), according to the European industry group, IFMPA, which points to process development and visual inspection as examples of areas where...
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Scout-Triggered Proteomics Sharpens HCP Control
Host-cell proteins (HCPs) remain one of bioprocessing’s most stubborn analytical headaches. These residual impurities, shed by production cells during manufacturing, can survive purification and threaten both...
-
Endpoints News3 months ago
After tumultuous year, Sarepta plots rebound with early data on RNA therapies
Sarepta Therapeutics reported promise in initial findings from clinical studies of two RNA muscle disease treatments, as the company maps out a future beyond its controversial...
-
Endpoints News3 months ago
Beam looks to accelerated approval for AATD base editing after promising update
Beam Therapeutics has provided a much-awaited update on its therapy that uses a form of CRISPR called base editing to precisely fix a single genetic typo...
-
Biotech Industry Intelligence3 months ago
Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
-
BioPharma Dive – AI / Data3 months agoSarepta sees early success with RNAi drugs from Arrowhead
Long-awaited results from Phase 1/2 studies lifted Sarepta’s stock and, according to the company, suggest potential for two medicines to treat muscle-weakening conditions.
-
GEN – Genetic Engineering & Biotechnology News3 months agoRentschler Highlights Milford Site Progress and Growth
During a gathering of Massachusetts political and company officials earlier this week, Rentschler Biopharma, a CDMO headquartered in Laupheim, Germany, cited the continued evolution and progress...
-
Biotech Industry Intelligence3 months ago
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
-
AI & Machine Learning in Biotechnology3 months agoSTAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugs
Sarepta Therapeutics’ next crop of medicines for muscular dystrophy appear to be safe and effective in early clinical trials, the company said, a positive though incremental...
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
